The AI race is still thriving in 2026. With the first month of the year complete, it's clear that there is one trend that isn't going away: artificial intelligence. AI is going to be prevalent throughout 2026 (spoiler alert: It will also be that way for the next five years), and there are few better places to invest fresh capital than the computing leaders. By investing in AI computing companies, ...
The AI race is still thriving in 2026. With the first month of the year complete, it's clear that there is one trend that isn't going away: artificial intelligence. AI is going to be prevalent throughout 2026 (spoiler alert: It will also be that way for the next five years), and there are few better places to invest fresh capital than the computing leaders. By investing in AI computing companies, you're picking stocks that are making money right now and aren't dependent on the overall success of the generative AI trend. Investors won't know the full impact of generative AI for many years, and by then, trillions of dollars will have been spent with Nvidia (NVDA 2.89%), Broadcom (AVGO 0.07%), and Taiwan Semiconductor (TSM +3.23%). This makes these three the best buys of February, and investors should consider loading up on them this month. Nvidia and Broadcom Nvidia and Broadcom are each making computing units, but they are taking different approaches. Nvidia designs graphics processing units (GPUs), which are suited for a wide variety of tasks. Broadcom designs custom AI chips, which are designed for a specific workload in mind. Each of these companies is seeing rapid revenue growth, with Nvidia's data center division (which encompasses its AI-focused products) growing to a 66% pace in the third quarter of fiscal year (FY) 2026 (ending Oct. 26) and Broadcom's AI semiconductor division rising at a 74% pace. Expand NASDAQ : NVDA Nvidia Today's Change ( -2.89 %) $ -5.52 Current Price $ 185.61 Key Data Points Market Cap $4.5T Day's Range $ 184.88 - $ 190.30 52wk Range $ 86.62 - $ 212.19 Volume 670K Avg Vol 181M Gross Margin 70.05 % Dividend Yield 0.02 % As its clients build increased computing capacity, demand for each of their products will likely continue to rise. This makes them both worthy investments. By splitting your allocation evenly between the two, I think investors are best set up for success. Even though Nvidia GPUs are designed for a broader purpose, they wo...
Key Points Nvidia and Broadcom are providing their clients with two viable computing options. Taiwan Semiconductor manufactures the chips for both companies. 10 stocks we like better than Nvidia › With the first month of the year complete, it's clear that there is one trend that isn't going away: artificial intelligence. AI is going to be prevalent throughout 2026 (spoiler alert: It will also be t...
Key Points Nvidia and Broadcom are providing their clients with two viable computing options. Taiwan Semiconductor manufactures the chips for both companies. 10 stocks we like better than Nvidia › With the first month of the year complete, it's clear that there is one trend that isn't going away: artificial intelligence. AI is going to be prevalent throughout 2026 (spoiler alert: It will also be that way for the next five years), and there are few better places to invest fresh capital than the computing leaders. By investing in AI computing companies, you're picking stocks that are making money right now and aren't dependent on the overall success of the generative AI trend. Investors won't know the full impact of generative AI for many years, and by then, trillions of dollars will have been spent with Nvidia (NASDAQ: NVDA), Broadcom (NASDAQ: AVGO), and Taiwan Semiconductor (NYSE: TSM). Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » This makes these three the best buys of February, and investors should consider loading up on them this month. Nvidia and Broadcom Nvidia and Broadcom are each making computing units, but they are taking different approaches. Nvidia designs graphics processing units (GPUs), which are suited for a wide variety of tasks. Broadcom designs custom AI chips, which are designed for a specific workload in mind. Each of these companies is seeing rapid revenue growth, with Nvidia's data center division (which encompasses its AI-focused products) growing to a 66% pace in the third quarter of fiscal year (FY) 2026 (ending Oct. 26) and Broadcom's AI semiconductor division rising at a 74% pace. As its clients build increased computing capacity, demand for each of their products will likely continue to rise. This makes them both worthy investments. By splitting your allocation evenly between the two, I think investors are best set ...
(RTTNews) - BellRing Brands, Inc (BRBR) revealed a profit for first quarter that Drops, from the same period last year The company's earnings came in at $43.7 billion, or $0.36 per share. This compares with $76.9 billion, or $0.59 per share, last year. Excluding items, BellRing Brands, Inc reported adjusted earnings of $44.7 billion or $0.37 per share for the period. The company's revenue for the ...
(RTTNews) - BellRing Brands, Inc (BRBR) revealed a profit for first quarter that Drops, from the same period last year The company's earnings came in at $43.7 billion, or $0.36 per share. This compares with $76.9 billion, or $0.59 per share, last year. Excluding items, BellRing Brands, Inc reported adjusted earnings of $44.7 billion or $0.37 per share for the period. The company's revenue for the period rose 0.8% to $537.3 billion from $532.9 billion last year. BellRing Brands, Inc earnings at a glance (GAAP) : -Earnings: $43.7 Bln. vs. $76.9 Bln. last year. -EPS: $0.36 vs. $0.59 last year. -Revenue: $537.3 Bln vs. $532.9 Bln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
(RTTNews) - Spire Inc. (SR) announced earnings for its first quarter that Increases, from last year The company's bottom line totaled $91.2 million, or $1.54 per share. This compares with $77.5 million, or $1.34 per share, last year. Excluding items, Spire Inc. reported adjusted earnings of $108.4 million or $1.77 per share for the period. The company's revenue for the period rose 13.9% to $762.2 ...
(RTTNews) - Spire Inc. (SR) announced earnings for its first quarter that Increases, from last year The company's bottom line totaled $91.2 million, or $1.54 per share. This compares with $77.5 million, or $1.34 per share, last year. Excluding items, Spire Inc. reported adjusted earnings of $108.4 million or $1.77 per share for the period. The company's revenue for the period rose 13.9% to $762.2 million from $669.1 million last year. Spire Inc. earnings at a glance (GAAP) : -Earnings: $91.2 Mln. vs. $77.5 Mln. last year. -EPS: $1.54 vs. $1.34 last year. -Revenue: $762.2 Mln vs. $669.1 Mln last year. -Guidance: Full year EPS guidance: $ 5.25 To $ 5.45 The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
BalkansCat Tech giant HP ( HPQ ) said on Tuesday that Enrique Lores has stepped down as CEO and a member of its board of directors, effective immediately. In a statement, HP said Lores had stepped down to pursue another professional opportunity. He will be replaced by board member Bruce Broussard on an interim basis. With the decision, HP's board of directors has formed a CEO search committee to i...
BalkansCat Tech giant HP ( HPQ ) said on Tuesday that Enrique Lores has stepped down as CEO and a member of its board of directors, effective immediately. In a statement, HP said Lores had stepped down to pursue another professional opportunity. He will be replaced by board member Bruce Broussard on an interim basis. With the decision, HP's board of directors has formed a CEO search committee to identify the company’s next CEO and has hired a global executive search firm to help with the matter. In addition to the executive shakeup, HP reaffirmed its outlook for the first-quarter and full-year, previously issued on Nov. 25. For the first-quarter, HP expects to earn between $0.73 and $0.81 per share on an adjusted basis. For the full-year, adjusted earnings are forecast to be between $2.90 and $3.20 per share. Full-year free cash flow is expected to be between $2.8B and $3B. HP will report fiscal first-quarter results on Feb. 24. HP shares fell 2.2% in premarket trading. More on HP HP Inc.: A Share Cannibal Trading At Cycle Lows HP Inc.: Near-Term Earnings Outlook Became Weaker Than I Expected (Rating Downgrade) HP Inc.: A Better Bargain As Cost Initiatives Yield Fruit (Upgrade) HP shares fell for seven consecutive sessions Notable analyst calls this week: Intel, AMD and Adobe among top picks
In this article PFE NVO Follow your favorite stocks CREATE FREE ACCOUNT Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it acquired through Metsera , drove solid weight loss when taken once a month in a mid-stage trial. Patients with obesity or who are overweight lost up to 12.3% of their weight compared with placebo at week 28 in the o...
In this article PFE NVO Follow your favorite stocks CREATE FREE ACCOUNT Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it acquired through Metsera , drove solid weight loss when taken once a month in a mid-stage trial. Patients with obesity or who are overweight lost up to 12.3% of their weight compared with placebo at week 28 in the ongoing phase two study. The injection's weight loss was up to 10.5% when analyzing all patients regardless of discontinuations. The data offer early evidence that the injection can be administered less frequently than existing drugs without sacrificing efficacy, which could be a major boost for Pfizer. It's trying to enter a market dominated by Eli Lilly and Novo Nordisk 's weekly injections, with a strong new entrant in Novo's daily pill. Pfizer plans to advance 10 phase three trials on the injection, called PF'3944, this year. "These topline results ... reinforce the potential of PF'3944 as a monthly treatment with competitive efficacy," said Dr. Jim List, Pfizer's chief internal medicine officer, in a release. The trial randomized patients to gradually switch from weekly to monthly injections of Pfizer's treatment. No plateau was observed after patients transitioned to monthly dosing, the company said.
A Hong Kong taxi driver has been fined HK$1,000 (US$128) for rude behaviour, having allegedly thrown a passenger’s change out of the window after she had asked him to slow down. Magistrate Winnie Lau Yee-wan at West Kowloon Court convicted taxi driver Lam Ching-fung of behaving rudely towards a female passenger who had booked his cab from Hong Kong International Airport to a residential complex in...
A Hong Kong taxi driver has been fined HK$1,000 (US$128) for rude behaviour, having allegedly thrown a passenger’s change out of the window after she had asked him to slow down. Magistrate Winnie Lau Yee-wan at West Kowloon Court convicted taxi driver Lam Ching-fung of behaving rudely towards a female passenger who had booked his cab from Hong Kong International Airport to a residential complex in Hung Hom on December 7, 2024. Lam denied a summary charge of behaving “other than in a civil and orderly manner”, contrary to the general conduct requirements for public transport drivers under the Road Traffic (Public Service Vehicles) Regulations. Advertisement In passenger Ng Yuk-lan’s testimony, she said she used a speedometer app to find that the driver was travelling at about 120 km/h (75mph), when the maximum speed limit on the road was 100 km/h. Ng told the court she then asked Lam to slow down, but he snapped at her: “Don’t call a taxi next time. I am out here making a living. You can choose not to take it.” Advertisement When they arrived at their destination, Ng said she paid HK$300 in cash and asked for a receipt. She testified that when Lam handed back her change, he threw a HK$20 banknote out of the window.
AMETEK ( AME ) announced its acquisition of LKC Technologies, strengthening its position in ophthalmic diagnostics. LKC Technologies, based in Germantown, Maryland, develops portable devices for detecting early signs of diabetic retinopathy and other vision-threatening conditions The company joins AMETEK's Electronic Instruments Group, integrating with the Ultra Precision Technologies Reichert bus...
AMETEK ( AME ) announced its acquisition of LKC Technologies, strengthening its position in ophthalmic diagnostics. LKC Technologies, based in Germantown, Maryland, develops portable devices for detecting early signs of diabetic retinopathy and other vision-threatening conditions The company joins AMETEK's Electronic Instruments Group, integrating with the Ultra Precision Technologies Reichert business to expand ophthalmic offerings. More on Ametek Ametek: Q3 Reacceleration, Strong Europe, And A Playbook That Keeps Compounding Ametek beats top-line and bottom-line estimates; initiates Q1 and FY26 outlook Ametek Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Ametek Historical earnings data for Ametek
TransDigm Group press release ( TDG ): Q1 Non-GAAP EPS of $8.23 beats by $0.19 . Revenue of $2.29B (+13.9% Y/Y) beats by $40M . EBITDA As Defined of $1,197 million, up 13% from $1,061 million in the prior year's quarter; EBITDA As Defined margin of 52.4%. Upward revision to fiscal 2026 financial guidance. TransDigm now expects fiscal 2026 financial guidance to be as follows: Net sales are anticipa...
TransDigm Group press release ( TDG ): Q1 Non-GAAP EPS of $8.23 beats by $0.19 . Revenue of $2.29B (+13.9% Y/Y) beats by $40M . EBITDA As Defined of $1,197 million, up 13% from $1,061 million in the prior year's quarter; EBITDA As Defined margin of 52.4%. Upward revision to fiscal 2026 financial guidance. TransDigm now expects fiscal 2026 financial guidance to be as follows: Net sales are anticipated to be in the range of $9,845 million to $10,035 million compared with $8,831 million in fiscal 2025 (prior $9,750 million to $9,950 million) vs. $9.93B consensus , an increase of 12.6% at the midpoint (an increase of $90 million at the midpoint from prior guidance); Net income is anticipated to be in the range of $1,952 million to $2,064 million compared with $2,074 million in fiscal 2025, a decrease of 3.2% at the midpoint primarily due to additional interest expense relating to the financing activities completed during the fourth quarter of fiscal 2025 (an increase of $42 million at the midpoint from prior guidance); Earnings per share is expected to be in the range of $32.47 to $34.39 per share based upon weighted average shares outstanding of 58.3 million shares, compared with $32.08 per share in fiscal 2025, which is an increase of 4.2% at the midpoint (an increase of $0.86 per share at the midpoint from prior guidance); EBITDA As Defined is anticipated to be in the range of $5,140 million to $5,280 million compared with $4,760 million in fiscal 2025, an increase of 9.5% at the midpoint (an increase of $60 million at the midpoint from prior guidance and corresponding to an EBITDA As Defined margin guide of approximately 52.4% for fiscal 2026); Adjusted earnings per share is expected to be in the range of $37.42 to $39.34 per share compared with $37.33 per share in fiscal 2025 (prior $36.49 to $38.53 per share) vs. $38.62 consensus , an increase of 2.8% at the midpoint compared to prior year (an increase of $0.87 per share at the midpoint from prior guidance); and F...
Monty Rakusen/DigitalVision via Getty Images Investment action I reiterated a hold rating for Sandvik ( SDVKY ) previously, as I thought the upside was still not attractive given the share price rally and the valuation at 20x forward PE. My view is now a buy. Q4 2025 delivered the revenue conversion and margin proof points I was waiting for. Organic growth is catching up to orders, the industrial ...
Monty Rakusen/DigitalVision via Getty Images Investment action I reiterated a hold rating for Sandvik ( SDVKY ) previously, as I thought the upside was still not attractive given the share price rally and the valuation at 20x forward PE. My view is now a buy. Q4 2025 delivered the revenue conversion and margin proof points I was waiting for. Organic growth is catching up to orders, the industrial demand cycle is recovering nicely, and margin quality has improved. With the earnings growth runway clearer now, I think the current valuation is not as big of a concern anymore. Earnings Review Previously in Q3 2025, I acknowledged the strength in orders but was still cautious because of timing. Orders were strong, but revenue was not converting fast enough to give me confidence in near-term growth inflection. Things have changed in Q4 . While the headline reported revenue growth of 1% y/y, which looks weak, that number is actually misleading. FX was a major drag, and if we strip that out, organic revenue growth came in at 12% y/y. That is the right figure to track orders conversion, as that 12% means that revenue is now growing at nearly the same pace as orders. This is exactly what I was waiting for, as it shows that supply chain constraints are easing. Segment data support this framing. Mining and Rock Solutions delivered 11% y/y organic order growth, while Machining & Manufacturing Solutions saw organic orders up 15% y/y. Margins came in strong too. Adj. EBITA was SEK 6,373 million (19.6% margin). While margin was flat y/y, this is actually a very bullish outcome, as SDVKY was able to hold margins steady despite the FX headwinds. Recovery strength I have also become more confident in the industrial cycle recovery narrative. Last October, my view was to lean neutral, as the early signals were not convincing enough. SDVKY gave me the datapoints I needed in Q4 2025. The 15% y/y organic growth in Machining & Manufacturing Solutions is the most glaring datapoint, but it is ...
Monty Rakusen/DigitalVision via Getty Images Investment Action I reiterated a hold rating for Sandvik ( SDVKY ) previously, as I thought the upside was still not attractive given the share price rally and the valuation at 20x forward PE. My view is now a buy. Q4 2025 delivered the revenue conversion and margin proof points I was waiting for. Organic growth is catching up to orders, the industrial ...
Monty Rakusen/DigitalVision via Getty Images Investment Action I reiterated a hold rating for Sandvik ( SDVKY ) previously, as I thought the upside was still not attractive given the share price rally and the valuation at 20x forward PE. My view is now a buy. Q4 2025 delivered the revenue conversion and margin proof points I was waiting for. Organic growth is catching up to orders, the industrial demand cycle is recovering nicely, and margin quality has improved. With the earnings growth runway clearer now, I think the current valuation is not as big of a concern anymore. Earnings Review Previously in Q3 2025, I acknowledged the strength in orders but was still cautious because of timing. Orders were strong, but revenue was not converting fast enough to give me confidence in near-term growth inflection. Things have changed in Q4 . While the headline reported revenue growth of 1% y/y, which looks weak, that number is actually misleading. FX was a major drag, and if we strip that out, organic revenue growth came in at 12% y/y. That is the right figure to track orders conversion, as that 12% means that revenue is now growing at nearly the same pace as orders. This is exactly what I was waiting for, as it shows that supply chain constraints are easing. Segment data support this framing. Mining and Rock Solutions delivered 11% y/y organic order growth, while Machining & Manufacturing Solutions saw organic orders up 15% y/y. Margins came in strong too. Adj. EBITA was SEK 6,373 million (19.6% margin). While margin was flat y/y, this is actually a very bullish outcome, as SDVKY was able to hold margins steady despite the FX headwinds. Recovery Strength I have also become more confident in the industrial cycle recovery narrative. Last October, my view was to lean neutral, as the early signals were not convincing enough. SDVKY gave me the data points I needed in Q4 2025. The 15% y/y organic growth in Machining & Manufacturing Solutions is the most glaring data point, but it i...
A huge global rally in stocks is underway today after Palantir delivered yet another blockbuster earnings call that blew through analysts’ expectations yesterday and—separately—a poll of manufacturers showed they were surprisingly optimistic about the future. Palantir stock was up 10.86% in overnight trading, after closing 0.81% yesterday. Nasdaq 100 futures rose 0.41% this morning. Apple, Alphabe...
A huge global rally in stocks is underway today after Palantir delivered yet another blockbuster earnings call that blew through analysts’ expectations yesterday and—separately—a poll of manufacturers showed they were surprisingly optimistic about the future. Palantir stock was up 10.86% in overnight trading, after closing 0.81% yesterday. Nasdaq 100 futures rose 0.41% this morning. Apple, Alphabet, and Amazon also rose yesterday and remained buoyant in overnight trading. S&P 500 futures were up 0.14% this morning after the index closed up 0.54% yesterday. Those gains came after markets in Asia closed strongly up today. Japan’s Nikkei 225 was up 3.92%; the South Korea KOSPI was up 6.84%. Two factors were driving markets back toward record highs this morning: The Palantir results show that spending on AI is set to continue for the foreseeable future—putting fears that AI is a bubble on the backburner. And the Institute for Supply Management’s manufacturing index yesterday showed a sharp and unexpected increase in optimism among factory purchasing executives, boosting non-tech stocks. That’s why the tech-heavy Nasdaq and the broader S&P both went up even though Nvidia, Oracle, Meta, Microsoft, and Tesla—Magnificent 7 stocks that have the power to move the entire market—all declined. Ohsung Kwon and his team of analysts at Wells Fargo noted that 167 companies in the S&P 500 have reported Q4 earnings so far—and their earnings are 5% above the consensus. In addition, 68% of companies said they expected to increase their capital expenditure (“capex”) above analysts’ expectations. “We expect higher capex … and volume growth in 2026,” he told clients. All that spending suggests AI companies won’t run out of money any time soon. Palantir’s results were so strong that some on Wall Street think this level of growth might be unsustainable. At Jefferies, Brent Thill and his team warned of “tougher comps ahead,” meaning that comparable percentage growth in earnings and revenues i...
US equity futures were mostly pointing higher on Tuesday as traders await a fresh batch of corporate Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles.
US equity futures were mostly pointing higher on Tuesday as traders await a fresh batch of corporate Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles.
NASA is postponing the planned launch of its Artemis II mission until at least March after engineers detected a hydrogen leak during a key fueling exercise. The agency said the delay will give teams time to analyze the data and repeat the procedure in a second “wet dress rehearsal.” As a result, astronauts Reid Wiseman, Victor Glover and Christina Koch of NASA, along with Jeremy Hansen of the Cana...
NASA is postponing the planned launch of its Artemis II mission until at least March after engineers detected a hydrogen leak during a key fueling exercise. The agency said the delay will give teams time to analyze the data and repeat the procedure in a second “wet dress rehearsal.” As a result, astronauts Reid Wiseman, Victor Glover and Christina Koch of NASA, along with Jeremy Hansen of the Canadian Space Agency will exit quarantine, which began in Houston on Jan. 21. Artemis II is designed to send astronauts around the moon for the first time since 1972. During this week’s test, officials encountered multiple technical issues, including an increase in the hydrogen leak, a problem with a valve tied to hatch pressurization, and intermittent audio disruptions, according to NASA. The rehearsal is meant to confirm that the Artemis II launch system, using the Space Launch System rocket built by Boeing ( BA ) and the Orion spacecraft developed by Lockheed Martin ( LMT ) can safely support a roughly 10-day mission that loops around the moon and returns to Earth. NASA also plans to use the mission to further validate Orion’s life-support systems ahead of Artemis III, which aims to land astronauts on the lunar surface later this decade. More on Boeing, Lockheed Martin Boeing: The Growth Is Just Starting Boeing Is Flying Steady Into 2026 Lockheed Martin Corporation (LMT) Q4 2025 Earnings Call Transcript Boeing secures $2.8B contract to upgrade South Korea's F-15 fighters Boeing, GE are said to review engine seal issue on 777X as testing continues
The automotive industry has struggled to adopt hydrogen at scale, but industrial users and data centers might have better luck. Vema Hydrogen inked a deal in December to supply California data centers, and now it has completed a pilot project in Quebec to power industry with hydrogen that it produces deep underground. The startup drills wells in regions with specific types of iron-rich rock that r...
The automotive industry has struggled to adopt hydrogen at scale, but industrial users and data centers might have better luck. Vema Hydrogen inked a deal in December to supply California data centers, and now it has completed a pilot project in Quebec to power industry with hydrogen that it produces deep underground. The startup drills wells in regions with specific types of iron-rich rock that release hydrogen gas when treated with water, heat, pressure, and some catalysts. Vema then draws the hydrogen to the surface and sells it to industrial users. “To supply the Quebec local market, which is about 100,000 tons per year, you would need 3 square kilometers, which is nothing,” Pierre Levin, CEO of Vema, told TechCrunch. Vema’s first pilot well will produce several tons of hydrogen per day, and next year, it plans to drill its first commercial well, which will reach 800 meters into the Earth. Vema expects to produce hydrogen from the first wells for less than $1 per kilogram, a widely used benchmark for clean hydrogen. Most hydrogen today is made by a process known as steam reformation of methane (SMR), in which steam is used to break hydrogen molecules off methane from natural gas. It’s energy intensive, and both the process to make steam and the chemical reaction itself release carbon dioxide. Less polluting sources of hydrogen exist, but they tend to cost more. Hydrogen from SMR costs between 70 cents and $1.60 per kilogram, according to the IEA. Capturing carbon from SMR can add around 50% to those prices, while the cleanest process, which uses zero carbon electricity to power an electrolyzer, drives costs up several fold. Techcrunch event TechCrunch Founder Summit 2026: Tickets Live On June 23 in Boston, more than 1,100 founders come together at TechCrunch Founder Summit 2026 for a full day focused on growth, execution, and real-world scaling. Learn from founders and investors who have shaped the industry. Connect with peers navigating similar growth stages. W...
Key Points Connecticut-based financial planner Tweedy, Browne sold 31,740 shares of Autoliv in the fourth quarter; the estimated trade value was $3.79 million based on quarterly average prices. Meanwhile, the position value decreased by $5.84 million, reflecting both trading and share price movements. As of December 31, the fund reported holding 400,924 ALV shares valued at $47.59 million. These 1...
Key Points Connecticut-based financial planner Tweedy, Browne sold 31,740 shares of Autoliv in the fourth quarter; the estimated trade value was $3.79 million based on quarterly average prices. Meanwhile, the position value decreased by $5.84 million, reflecting both trading and share price movements. As of December 31, the fund reported holding 400,924 ALV shares valued at $47.59 million. These 10 stocks could mint the next wave of millionaires › On February 2, Tweedy, Browne Co disclosed in an SEC filing that it sold 31,740 shares of Autoliv (NYSE:ALV), an estimated $3.79 million trade based on quarterly average pricing. What happened In an SEC filing dated February 2, Connecticut-based financial planner Tweedy, Browne reported selling 31,740 shares of Autoliv during the fourth quarter. The estimated transaction value was $3.79 million, calculated using the average unadjusted closing price for the period. The reduction brought the stake to 400,924 shares at quarter’s end. The value of the fund’s Autoliv position dropped by $5.84 million, reflecting both the sale and market movement over the quarter. What else to know Tweedy, Browne’s stake in Autoliv now represents 3.84% of its $1.24 billion reportable U.S. equity AUM. Top holdings after the filing: NASDAQ: IONS: $195.00 million (15.8% of AUM) NYSE: CNH: $186.07 million (15.0% of AUM) NYSE: KOF: $112.59 million (9.1% of AUM) UNK: BRK-A: $108.69 million (8.8% of AUM) NASDAQ: GOOGL: $62.46 million (5.0% of AUM) As of February 2, ALV shares were priced at $120.49, up 32.0% over the past year and outperforming the S&P 500 by 12.78 percentage points. Company overview Metric Value Revenue (TTM) $10.81 billion Net Income (TTM) $735.00 million Dividend Yield 2.59% Price (as of market close 2/2/26) $120.49 Company snapshot Autoliv develops and manufactures passive safety systems, including airbags, seatbelts, steering wheels, inflator technologies, and pedestrian protection solutions. The company generates revenue through ...